Skip to main content
Clinical Trials/NCT00630292
NCT00630292
Terminated
N/A

Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast Tumors

University of North Carolina, Chapel Hill1 site in 1 country6 target enrollmentMarch 2008
ConditionsBreast Cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
University of North Carolina, Chapel Hill
Enrollment
6
Locations
1
Primary Endpoint
Amount of Blood Vessel Tortuosity in Breast With Known Cancer
Status
Terminated
Last Updated
15 years ago

Overview

Brief Summary

This is a pilot study designed to explore the feasibility of non-invasively diagnosing the presence of cancer in the breast using non-invasive magnetic resonance imaging (MRI) methods and an analysis of vessel shape defined from these magnetic resonance images.

Registry
clinicaltrials.gov
Start Date
March 2008
End Date
December 2009
Last Updated
15 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • adult women (age \>= 18),
  • with Histologically documented newly diagnosed stage II-IV invasive breast cancer appropriate for neoadjuvant (preoperative) systemic therapy.
  • ECOG performance status of 0, 1, or 2 at the initiation of the study.

Exclusion Criteria

  • pregnant women
  • women with contralateral mastectomies
  • known bilateral tumors
  • subjects prone to claustrophobia
  • contraindicated to have MRI
  • mentally impaired
  • not fluent in english

Outcomes

Primary Outcomes

Amount of Blood Vessel Tortuosity in Breast With Known Cancer

Time Frame: up to two weeks prior to start of chemotheraphy

Amount of vessel tortuosity before the start of neoadjuvant chemotherapy and at the end of neoadjuvant chemotherapy

Study Sites (1)

Loading locations...

Similar Trials